Security key
71715X203
PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB)
CUSIP: 71715X203
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 825,885
- Total 13F value
- $1,577,022
- Share change
- -192,646
- SEC-reported price per share
- $1.91
- Number of holders
- 23
- Value change
- -$369,360
- Number of buys
- 5
- Number of sells
- 12
- Shares outstanding
- 10,666,413
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
23
Top holders
10
PMCB full security history
Ownership snapshot
Full 13F holder table
PharmaCyte Biotech, Inc. SEC filings
PharmaCyte Biotech, Inc. company facts
PharmaCyte Biotech, Inc. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of PMCB - PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
K2 PRINCIPAL FUND, L.P.
Disclosed value leader
K2 PRINCIPAL FUND, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 3.1%
Showing 1-6 of 15 holder rows.
Quick read
K2 PRINCIPAL FUND, L.P. leads the comparable SEC ownership view at 3.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens K2 PRINCIPAL FUND, L.P.'s linked filing trail.
Comparable ownership
Top 5
K2 PRINCIPAL FUND, L.P.
3.1%
VANGUARD GROUP INC
1.8%
GEODE CAPITAL MANAGEMENT, LLC
1.7%
EQUITEC PROPRIETARY MARKETS, LLC
0.78%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0.51%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. |
13F
Company
|
3.1%
|
$641,906
327,503 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
1.8%
|
$377,079
192,387 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.7%
|
$346,171
176,605 shares
|
— | 30 Jun 2024 |
| EQUITEC PROPRIETARY MARKETS, LLC |
13F
Company
|
0.78%
|
$162,145
82,727 shares
|
— | 30 Jun 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.51%
|
$107,474
54,834 shares
|
— | 30 Jun 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.45%
|
$95,060
48,500 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
23
Shares
825,885
Rows available
23
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
25
Q3 2024 holders
23
Holder diff
-2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|